Hemmer- und Induktoren von CYP-450
Cytochromen |
|
|
|
|
|
|
|
- idR erniedrigte
Bioverfügbarkeit der betroffenen
Medikamente! |
|
|
|
|
|
1A2 |
2C9 |
2C19 |
2D6 |
2E1 |
3A4 |
|
betroffene Medikamente (noch
einordnen: Digitoxin)
|
|
|
|
Theophyllin |
|
|
|
|
|
|
Terfenadin |
|
|
|
|
|
|
orale
Antikoagulantien |
|
ð |
|
unzureichende
Thromboseprophyllaxe |
|
|
orale
Kontrazeptiva |
|
ð |
|
unsichere
Kontrazeption |
|
|
Glukokortikoide |
|
|
|
|
|
|
|
|
|
|
Theophyllin |
|
|
|
|
|
|
Terfenadin |
|
|
|
|
|
|
orale
Antikoagulantien |
|
ð |
|
unzureichende
Thromboseprophyllaxe |
|
|
orale
Kontrazeptiva |
|
ð |
|
unsichere
Kontrazeption |
|
|
Glukokortikoide |
|
|
|
|
|
|
Methadon |
|
|
|
|
|
|
Antiepileptika |
Barbiturate
(zB Phenobarbital) |
|
|
|
|
|
|
Phenytoin |
|
|
|
|
|
|
Carbamazepin |
|
|
|
|
|
|
Antibiotika |
Rifampicin |
|
|
|
|
|
|
Isoniazid |
|
|
|
|
|
|
Tabak, Teer: Rauchen! |
|
|
|
|
|
|
|
Johanniskraut |
|
|
|
|
|
|
|
Alkohol |
|
|
|
|
|
|
|
|
|
|
|
klinisch relevante
Hemmer
der CYP-450 |
|
|
- idR erhöhte
Bioverfügbarkeit der betroffenen
Medikamente! |
|
|
|
|
|
1A2 |
2C9 |
2C19 |
2D6 |
2E1 |
3A4 |
|
betroffene Medikamente (noch
einordnen: orale Antidiabetika, Phenytoin?,
Carbamazepin?)
|
|
|
|
Theophyllin |
|
|
|
|
|
|
Terfenadin |
|
|
|
|
|
|
orale
Antikoagulantien |
|
ð |
|
verstärkte
Blutungsneigung |
|
|
|
|
|
|
Theophyllin |
|
ð |
|
Intox.-Gefahr |
|
|
Terfenadin |
|
|
|
|
|
|
orale
Antikoagulantien |
|
ð |
|
verstärkte
Blutungsneigung |
|
|
Makrolide |
Erythromycin |
Erythrocin® |
|
|
|
|
|
|
Roxithromycin |
Rulid |
|
|
|
|
|
|
Clarithromycin
|
Klacid® |
|
|
|
|
|
|
Josamycin |
|
|
|
|
|
|
|
Azole |
Itraconazol |
|
|
|
|
|
|
|
Ketokonazol |
|
|
|
|
|
|
|
|
Omeprazol |
Antramups® |
|
|
|
|
|
|
Chinolone |
Ciprofloxacin |
|
|
|
|
|
|
|
Norfloxacin |
|
|
|
|
|
|
|
Statine |
Simvastatiin |
Zocor |
|
|
|
|
|
|
Fluvastatin |
Lescol |
|
|
|
|
|
|
Antiarrhythmika |
Chinidin |
|
|
|
|
|
|
|
Amiodaron |
|
|
|
|
|
|
|
Ca-Antagonisten |
Diltiazem |
|
|
|
|
|
|
|
Verapamil |
|
|
|
|
|
|
|
Serotonin-Reuptake-Inhibitoren |
Fluvoxamin |
Floxyfral |
|
|
|
|
|
|
Fluoxetin |
Fluctine |
|
|
|
|
|
|
Paroxetin |
Deroxat |
|
|
|
|
|
|
Nefazodon |
Nefadar |
|
|
|
|
|
|
HIV-Protease-Inhibitoren |
Ritonavir |
|
|
|
|
|
|
|
|
Disulfiram |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
quellen |
verlauf |
links |
|
|
|
1 |
|
Pharmaskript Prof.
Lauterburg, Unibe, S. 6 (Hemmer- und
Induktoren) bezw. S.5 |
|
2 |
|
x |
|
3 |
|
x |
|
4 |
|
x |
|
|
begonnen |
|
20.06.04 |
|
|
aktualisiert: |
|
07.08.04 |
|
(Omeprazol) |
|
|
08.08.04 |
|
(Methadon) |
broken links: |
|
20.06.04 |
|
|
rückmeldungen
via emaille |
legende / farbcode |
|
|
|
|
|